Lobbying Filing Details

Total Spending

$1,350,000

Activities

5

Lobbyists

4

Gov't Entities

30

Filing Information
Filing UUID:
c4c093c8-0d56-4868-a0cd-6d3e7957f792
Type:
Q1 - 1st Quarter - Report
Period:
2018 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 20, 2018 at 8:07 PM
Income:
$0
Expenses:
$1,350,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Elizabeth Hall
Registrant
ELEVANCE HEALTH, INC.

Health Benefits Company

Washington, District of Columbia
Client
ELEVANCE HEALTH, INC.
District of Columbia, United States of America
Lobbying Activities (5)
Activity 1
Consumer Issues/Safety/Products

Telephone Consumer Protection Act

Lobbyists (2)
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
Government Entities (6)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
  • Labor, Dept of (DOL)
  • ... and 1 more
Activity 2
Health Issues

ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment, transitional policies)
ACA reform (reconciliation, individual mandate, cost sharing reduction subsidies, reinsurance)
The Bipartisan Budget Act of 2018 (H.R. 1892)
Bipartisan Health Care Stabilization Act of 2018 (Amendment to S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018)
Creating and Restoring Equal Access To Equivalent Samples (CREATES) Act of 2017 (S. 974 and H.R. 2212)
Overdose Prevention and Patient Safety Act (H.R. 3545)
Jessies Law (H.R. 5009)
Prescription Drug Monitoring Act of 2017 (S. 778)
CARA 2.0 Act of 2018 (S. 2456)
Consolidated Appropriations Act, 2018 (H.R. 1625)
Lower Premiums Through Reinsurance Act (S. 1835)
Mental health and substance use (42 CFR Part 2)
Individual market and exchange stabilization
Association health plans
Short Term Limited Duration Plans
Out of network billing
ACA third party payments
Telehealth
Price of prescription drugs
Opioid addiction issues and response (prescription drug monitoring programs)

Lobbyists (4)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • PATRICK VELLIKY
Government Entities (6)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
  • Labor, Dept of (DOL)
  • ... and 1 more
Activity 3
Insurance

ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment, transitional policies)
ACA reform (reconciliation, individual mandate, cost sharing reduction subsidies, reinsurance)
The Bipartisan Budget Act of 2018 (H.R. 1892)
Bipartisan Health Care Stabilization Act of 2018 (Amendment to S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018)
Creating and Restoring Equal Access To Equivalent Samples (CREATES) Act of 2017 (S. 974 and H.R. 2212)
Overdose Prevention and Patient Safety Act (H.R. 3545)
Jessies Law (H.R. 5009)
Prescription Drug Monitoring Act of 2017 (S. 778)
CARA 2.0 Act of 2018 (S. 2456)
Consolidated Appropriations Act, 2018 (H.R. 1625)
Lower Premiums Through Reinsurance Act (S. 1835)
Mental health and substance use (42 CFR Part 2)
Individual market and exchange stabilization
Association health plans
Short Term Limited Duration Plans
Out of network billing
ACA third party payments
Telehealth
Price of prescription drugs
Opioid addiction issues and response (prescription drug monitoring programs)

Lobbyists (4)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • PATRICK VELLIKY
Government Entities (6)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
  • Labor, Dept of (DOL)
  • ... and 1 more
Activity 4
Medicare/Medicaid

Medicare Advantage (risk adjustment, coding intensity, encounter data, dual-eligible members, reauthorization of special need plans (including H.R. 3168), star ratings, normalization factors, stars contract consolidation)
Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017 (S. 870 and H.R. 4579)
Mental health and substance use (42 CFR Part 2)
The Bipartisan Budget Act of 2018 (H.R. 1892)
The Connect for Health Act of 2017 (H.R.2556 and S.1016)
Medicaid managed care
Medicaid expansion
Medicaid reform (block grants, per capita caps)
Medicaid and CHIP reauthorization
Medicaid actuarial soundness
Long-term services and supports
Medicare Part D
Clinical decision support
Medicare fraud, waste, and abuse
Opioid addiction issues and response (prescription drug monitoring programs)

Lobbyists (4)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • PATRICK VELLIKY
Government Entities (6)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
  • Labor, Dept of (DOL)
  • ... and 1 more
Activity 5
Taxation/Internal Revenue Code

To extend the one year moratorium and/or repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act (H.R. 246)
Healthcare Tax Relief Act (S. 1859)
Small Business and Family Health Tax Relief Act of 2017 (S. 1978)
The Bipartisan Budget Act of 2018 (H.R. 1892)
Tax exclusion for employer-sponsored health insurance

Lobbyists (4)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • PATRICK VELLIKY
Government Entities (6)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
  • Labor, Dept of (DOL)
  • ... and 1 more

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.